In:
Pediatrics, American Academy of Pediatrics (AAP), Vol. 87, No. 1 ( 1991-01-01), p. 124-124
Abstract:
To the Editor.— In a recent editorial, Abramson and Givner addressed the problem of using tetracycline in young children for therapy of presumed Rocky Mountain spotted fever (RMSF), due to the potential risk of tooth discoloration.1 The risk appears to depend on the specific agent used (doxycycline causes less staining than do other tetracyclines, possibly because of its lower binding to calcium) and the degree of exposure to tetracycline.2 Unfortunately, current therapeutic recommendations do not provide clear guidelines on the optimal dosage required to treat RMSF.
Type of Medium:
Online Resource
ISSN:
0031-4005
,
1098-4275
DOI:
10.1542/peds.87.1.124
Language:
English
Publisher:
American Academy of Pediatrics (AAP)
Publication Date:
1991
detail.hit.zdb_id:
1477004-0
Permalink